Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors
European urology oncology - Netherlands
doi 10.1016/j.euo.2019.11.001
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2019
Authors
Publisher
Elsevier BV